Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00043030 |
RATIONALE: Understanding why patients participate in a phase I clinical trial may help doctors plan better treatment for cancer.
PURPOSE: This clinical trial is studying to determine the reasons for participation, perceptions, and expectations of patients receiving treatment for cancer in phase I clinical trials.
Condition | Intervention |
---|---|
Cancer-Related Problem/Condition Unspecified Adult Solid Tumor, Protocol Specific |
Procedure: psychosocial assessment and care |
Study Type: | Interventional |
Official Title: | Survey Of Patient's Motivations, Perceptions, And Expectations In Phase I Clinical Trials |
Estimated Enrollment: | 120 |
Study Start Date: | June 2002 |
OBJECTIVES:
OUTLINE: Patients are interviewed over the phone to evaluate their perceptions, motivations, and expectations of phase I clinical trials. Patients complete a questionnaire comprising 24 questions over 30-45 minutes. Interviews are conducted within 1 week after enrolling in a phase I clinical trial (prior to the first dose of study agent) and then again 2 months later (or at the time the patient stops treatment). The first 10 patients enrolled complete an additional 6 questions over 15 minutes during the first interview to validate the questionnaire, but do not complete a second interview.
PROJECTED ACCRUAL: A total of 120 patients will be accrued for this study within 1 year.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Enrolled in a phase I clinical trial within the past week
PATIENT CHARACTERISTICS:
Age
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
Other
PRIOR CONCURRENT THERAPY:
Biologic therapy
Chemotherapy
Endocrine therapy
Radiotherapy
Surgery
Other
United States, Maryland | |
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support | |
Bethesda, Maryland, United States, 20892-1182 |
Principal Investigator: | Arlene Berman, RN | National Cancer Institute (NCI) |
Study ID Numbers: | CDR0000069497, NCI-02-C-0204C |
Study First Received: | August 5, 2002 |
Last Updated: | December 13, 2008 |
ClinicalTrials.gov Identifier: | NCT00043030 |
Health Authority: | United States: Federal Government |
psychosocial effects/treatment unspecified adult solid tumor, protocol specific |